BLES Biochemicals Inc. is a Canadian-controlled pharmaceutical company that excels in the manufacture of pulmonary surfactant, a critical biologic drug product designed to treat premature infants suffering from neonatal respiratory distress syndrome. As the market leader for pulmonary surfactant in Canada, BLES Biochemicals Inc. produces and distributes BLES® (bovine lipid extract surfactant), a unique product with no generic equivalents available. The company operates with a focus on improving health outcomes for infants globally, continuously seeking distribution partners committed to the same mission.

Services include:
– Biologics
– Drug Delivery Devices & Systems

BLES Biochemicals Inc. is dedicated to advancing healthcare solutions for premature infants and plays a vital role in the pharmaceutical industry. For more information, please visit blesbiochem.com.